PROK1 expression was notably lower in PCa patients with higher T-stage, N-stage, and Gleason scores (Fig. 10G–I) and was inversely correlated with prostate-specific antigen (PSA) levels (Fig. 10J). This evidence concerns the gene KLK3 and posterior cortical atrophy.